IP Library Granted Patent US 9,056,075
Granted Patent B2
US 9,056,075 · App. 14/305,979 · Granted Jun 16, 2015

Methods of inducing an immune response with compositions comprising a

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,056,075
App. No.
14/305,979
Granted
Jun 16, 2015
Kind
B2
Abstract

Two or more Neisserial proteins are joined such that they are translated as a single polypeptide chain. Hybrid proteins are represented by the formula NH 2 -A-[-X-L-] n -B—COOH where X is an amino acid sequence, L is an optional linker amino acid sequence. A is an optional N-terminal amino acid sequence, B is an optional C-terminal amino acid sequence, and n is an integer greater than 1. Proteins where each of the n —X— moieties shares sequence identity to each other —X— moiety, the protein is a ‘tandem protein’.

Claims (5)

1. A method of inducing an immune response in a subject comprising administering to the subject an effective amount of a composition comprising an aluminum salt adjuvant and an isolated protein comprising a Neisseria meningitidis protein having 80% or greater sequence identity to the amino acid sequence of SEQ ID NO: 19.

2. A method of inducing an immune response in a subject comprising administering to the subject an effective amount of a composition comprising an aluminum salt adjuvant and an isolated protein comprising a Neisseria meningitidis protein having 80% or greater sequence identity to the amino acid sequence of SEQ ID NO: 19, wherein the isolated protein is adsorbed to the aluminum salt adjuvant.

3. The method of claim 2 , wherein the aluminum salt adjuvant comprises aluminum phosphate.

4. The method of claim 1 , wherein the aluminum salt adjuvant comprises aluminum phosphate.

5. A method of inducing an immune response in a subject comprising administering to the subject an effective amount of a composition comprising an aluminum salt adjuvant and an isolated protein comprising a Neisseria meningitidis protein having 80% or greater sequence identity to the amino acid sequence of SEQ ID NO: 19, wherein the aluminum salt adjuvant comprises aluminum hydroxyphosphate.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2016
From: NOVARTIS VACCINES AND DIAGNOSTICS SRL
To: GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 040077/0722 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2015
From: NOVARTIS AG
To: GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 037148/0192 →
CHANGE OF NAME Recorded Jun 18, 2015
From: CHIRON S.R.L.
To: NOVARTIS VACCINES AND DIAGNOSTICS S.R.L.
Reel/Frame 035930/0128 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2015
From: PIZZA, MARIAGRAZIA
To: CHIRON S.R.L.
Reel/Frame 035934/0433 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2015
From: NOVARTIS VACCINES AND DIAGNOSTICS SRL
To: NOVARTIS AG
Reel/Frame 035977/0640 →